Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RMD · against 1,336 other Healthcare companies
Ranked #422 of 1,337 · scores higher than 68% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including RMD · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | RMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 4.6% | 1.5% | 76% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 6.5% | 4.2% | 64% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 5.0% | -1.0% | 79% | 20% | |
| Book yieldHigher is better · 1,306 reported | 20.1% | 37.9% | 29% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 422 | 4.0B EUR (≈$4.4B) | 68 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 422 | 302.7B USD | 68 | 63 |
| 422 | 13.9B EUR (≈$15.3B) | 68 | 78 |
| 422 | 213M EUR (≈$235M) | 68 | 40 |
| 422 | 32.8B USD | 68 | 69 |
| 422 | 16.2B THB (≈$453M) | 68 | 63 |
| 422 | 3.9B USD | 68 | 58 |
| 436 | 2.5B CNY (≈$345M) | 67 | 39 |
| 436 | 6.0B CNY (≈$841M) | 67 | 50 |